Protara Therapeutics Files Definitive Proxy Statement
Ticker: TARA · Form: DEF 14A · Filed: Apr 25, 2025 · CIK: 1359931
| Field | Detail |
|---|---|
| Company | Protara Therapeutics, Inc. (TARA) |
| Form Type | DEF 14A |
| Filed Date | Apr 25, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: proxy-statement, annual-meeting, corporate-governance
TL;DR
Protara Proxy Statement is IN: Shareholders vote on company matters June 11.
AI Summary
Protara Therapeutics, Inc. filed its definitive proxy statement on April 25, 2025, for its annual meeting on June 11, 2025. The company, formerly known as ArTara Therapeutics, Inc. and PROTEON THERAPEUTICS INC, is seeking shareholder approval for matters related to corporate governance and executive compensation. The filing provides details on the company's business operations and financial performance.
Why It Matters
This filing is crucial for shareholders as it outlines the proposals they will vote on at the upcoming annual meeting, impacting the company's future direction and leadership.
Risk Assessment
Risk Level: medium — Proxy statements often contain information about executive compensation, board proposals, and shareholder rights, which can be material to investors.
Key Numbers
- 20250611 — Annual Meeting Date (Shareholders will vote on proposals at this date.)
- 20250425 — Filing Date (The proxy statement was filed on this date.)
Key Players & Entities
- Protara Therapeutics, Inc. (company) — Registrant
- ArTara Therapeutics, Inc. (company) — Former Company Name
- PROTEON THERAPEUTICS INC (company) — Former Company Name
- 0001359931 (company) — Central Index Key
- 20250425 (date) — Filing Date
- 20250611 (date) — Meeting Date
FAQ
What is the primary purpose of this DEF 14A filing?
The primary purpose is to provide shareholders with information and solicit their votes for the annual meeting of shareholders scheduled for June 11, 2025.
When is Protara Therapeutics, Inc.'s annual meeting scheduled?
The annual meeting is scheduled for June 11, 2025.
What were Protara Therapeutics' former company names?
Protara Therapeutics, Inc. was formerly known as ArTara Therapeutics, Inc. and PROTEON THERAPEUTICS INC.
What is the filing date of this definitive proxy statement?
The definitive proxy statement was filed on April 25, 2025.
What is the company's Standard Industrial Classification code?
The company's Standard Industrial Classification code is 2836, which corresponds to BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES).
Filing Details
This Form DEF 14A (Form DEF 14A) was filed with the SEC on April 25, 2025 regarding Protara Therapeutics, Inc. (TARA).